Primary structure of a regulating factor, 15 kDa protein, of ATP synthase in yeast mitochondria  by Yoshida, Yukuo et al.
Volume 170, number 1 FEBS 1425 May 1984 
Primary structure of a regulating factor, 15 kDa protein, of 
ATP synthase in yeast mitochondria 
Yukuo Yoshida, Sadao Wakabayashi *, Hiroshi Matsubara*, Tadao Hashimoto 
and Kunio Tagawa+ 
Department of Physiological Chemistry, MedicaI School, Osaka University, Nakanoshima 4-3-57, Kita-ku, Osaka 
530 and *Department of Biology, Faculty of Science, Osaka University, Toyonaka, Osaka 560, Japan 
Received 20 February 1984 
The amino acid sequence of a factor, 15 kDa protein, which facilitates the formation of, and stabilizes 
the inactivated complex between mitochondrial ATPase and intrinsic inhibitor was established. The factor 
was found to be composed of 83 amino acid residues and to have an h4, of 9450, though the apparent M, 
was 15 000 when determined by SDS-polyacrylamide gel electrophoresis. The factor was characterized as 
a basic protein with 18 basic and 12 acidic amino acid residues. The amino acid sequence of the factor 
showed significant homology with those of yeast ATPase inhibitor and the 9 kDa protein which acts in 
concert with the 15 kDa protein in stabilizing the inactivated ATPase complex. 
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1. INTRODUCTION chloroplast [5] Fi-ATPase which mediate binding 
of the q8y complex to the membrane moiety, Fo. 
An intrinsic mitochondrial ATPase inhibitor has 
an inhibitory action on ATP-hydrolysis by 
FiFe-ATPase. The inhibitor forms an equimolar 
complex with the enzyme in the presence of ATP 
and Mg’+ , indicating that it is an essential subunit 
of FIFO-ATPase [l]. However, the inhibitor is 
readily dissociated from the complex in vitro and 
the enzyme becomes active when external ATP is 
removed [2]. In the previous report, it was shown 
that in the presence of two protein factors, named 
15 kDa and 9 kDa proteins, the ATPase inhibitor 
inactivated FIFO-ATPase very efficiently and the 
enzyme-inhibitor complex was stable even in the 
absence of ATP and Mg2+ [3]. It was also shown 
that the factors had no effect on stabilization of 
the complex between purified Fi-ATPase and the 
inhibitor. Thus it is highly likely that the factors 
mediate the binding between the inactivated 
Fr-ATPase and the mitochondrial membrane, like 
the 6- and c-subunits of bacterial [4] and 
The subunits, (Y, ,8 and y, of ATPases from 
various organisms correspond to each other. It has 
been shown, however, that bovine oligomycin 
sensitivity-conferring protein (OSCP) and the 
bovine a-subunit have homologous sequences with 
those of Escherichia coli 6- and c-subunits, respec- 
tively [6]. We recently determined the complete 
amino acid sequence of the small stabilizing factor, 
9 kDa protein, and found that the sequence was 
closely similar to that of yeast ATPase inhibitor 
and that both proteins have high homology with E. 
coli E- and a fragment of the bovine b-subunit [7]. 
Thus, the relationship of the smaller subunits, 6, f, 
ATPase inhibitor and OSCP is rather confusing. 
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Here, we determined the amino acid sequence of 
the large stabilizing factor, 15 kDa protein, 
purified from yeast, Saccharomyces cerevisiae, 
and compared its sequence with those of the other 
subunits of FIFO-ATPases of various organisms. 
It was found that the sequence of the factor show- 
ed significant homology with those of yeast AT- 
Pase inhibitor and the 9 kDa protein. 
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2. MATERIALS AND METHODS 
The stabilizing factor, 15 kDa protein, was 
purified from yeast mitochondria as in [3]. The 
purified preparation gave a single band with an ap- 
parent M, of 15 000 on SDS-polyacrylamide gel 
electrophoresis (PAGE) with chymotrypsinogen 
(25 000), myoglobin (17 500), cytochrome c (12400) 
and insulin (5500) as marker proteins. 
The procedures for sequence analysis were 
essentially the same as those in [7]. About 0.7 mg 
of the protein was subjected to automated Edman 
degradation in a solid-phase sequencer, LKB 4030, 
after activation of the protein with p- 
phenylenediisothiocyanate o achieve attachment 
of the aminopropyl glass beads [8]. The 
thiazolinone derivatives obtained at each step of 
degradation were converted to phenylthiohydan- 
toin (PTH) amino acids and the PTH amino acids 
were analyzed by thin-layer chromatography 
(TLC) [9] and/or high performance liquid 
chromatography (HPLC) in an Irica model 
LC-300 apparatus [7]. The amino terminal amino 
acid residue and the sequences of the peptides ob- 
tained by treatment of the protein with various 
proteases were determined by manual Edman 
degradation [lo]. 
About 10 mg of the protein were digested with 
0.2 mg of staphylococcal V8 protease in 1.2 ml of 
0.1 M Tris-HCl (pH 8.0) for 21 h at 40°C and the 
digest was applied to a Bio-gel P-6 column (2 x 
180 cm) equilibrated with 0.2 M NH4HCO3 buffer 
(pH 9.0). The fractions eluted from the column 
were each lyophilized and purified further by 
paper electrophoresis (Whatman 3 MM) at pH 6.5. 
A peptide (V-4) thus obtained was digested further 
with thermolysin and the resulting peptides were 
purified by HPLC as in [7]. 
Tryptic peptides of the succinylated 15 kDa pro- 
tein were prepared as follows. About 10 mg of the 
protein was succinylated with 100 mg of succinic 
anhydride at pH 8 in 6 M guanidine-HCl contain- 
ing 0.5 M NaHC03. The succinic anhydride was 
removed by dialysis against 0.1 M NHdHC03 (pH 
7.8) and the material was then hydrolyzed with 
0.2 mg of trypsin for 3 h. The digest was 
chromatographed on a column (2 x 180 cm) of 
Toyopearl HW-40 and developed with 0.2 M 
NHbHCO3 (pH 9.0). The fractions were lyophi- 
lized and purified further by paper electrophoresis 
at pH 6.5 and 3.6. 
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In addition, about 10 mg of the protein was 
digested with Achromobacter lysyl endopeptidase. 
The digest was chromatographed on Toyopearl 
HW-40 as described above and fractions obtained 
were purified further by HPLC and paper 
electrophoresis. 
3. RESULTS AND DISCUSSION 
The amino acid composition of the 15 kDa pro- 
tein is shown in table 1. The proteins contains no 
cysteine or methionine. The absence of cysteine 
was confirmed by calorimetric determination of 
sulfhydryl groups of the protein treated with 
dithiothreitol and 5,5’-dithio-bis-nitrobenzoic acid 
[ill. 
Solid-phase Edman degradation of 80 nmol 
(about 0.7 mg) of the protein showed that the 
Table 1 
Amino acid compositions of the yeast 15 kDa protein 
and the J-subunit of Fr-ATPase 
15 kDa protein S-Subunit 
1141 
mol/mol Sequence 
analysis 
Asp 
Asn 
Thr 
Ser 
Glu 
Gln 
Pro 
GlY 
Ala 
Val 
CYS 
Met 
Ile 
Leu 
TYr 
Phe 
LYS 
His 
Arg 
Trp 
12.35 
3.71 
5.06 
11.93 
4.75 
9.50 
1.34 
2.70 
- 
0 
4.02 
2.17 
1.93 
2.77 
10.17 
3.48 
4.13 
(12) 5 5 
(4) 
(5) 
(12) 
4 
6 
7 
18 
15 
(5) 
(10) 
(1) 
(3) 
_ 
Gj 
(2) 
(2) 
(3) 
(10) 
(3) 
(4) 
5 
5 
10 
1 
2 
0 
0 
4 
2 
2 
3 
11 
3 
4 
2 
4 
18 
11 
7 
Total (80) 83 121 
Calculated kf, 9454 11600 
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amino-terminal sequence up to residue 25 was 
X-X-Thr-Asn-X-Trp-Thr-Glu-X-Glu-Gly-X-Ala- 
Asn-Pro-X-Tyr-Phe-X-X-Thr-Gly-Asn-Tyr-Gly-. 
The amino terminal residue was identified as 
threonine by manual Edman degradation. The car- 
boxy1 terminal amino acid was hardly detected by 
carboxypeptidase Y digestion. 
The sequence study of the yeast 15 kDa protein 
is summarized in fig.1. There were 83 amino acid 
residues and basic residues exceeded acidic ones. 
The h4, calculated from the amino acid sequence 
was 9450, although it was estimated as 15000 by 
SDS-PAGE. Differences between the MS deter- 
mined by SDS-PAGE and calculated from the 
composition have also been observed in the cases 
of ATPase inhibitor and the other stabilizing fac- 
tor, 9 kDa protein. 
Repeated sequences were clearly observed in 
both ATPase inhibitor and the 9 kDa protein, sug- 
gesting gene duplication in the evolutionary past 
[7]. But no obvious repeated sequence was found 
in the 15 kDa protein. 
The secondary structure of the factor was de- 
duced as in [12]. The a-helical contents of the 
ATPase inhibitor, 13 and 9 kDa protein [7], were 
found to be high, but that of the 15 kDa protein 
was only 27%. Basic, acidic and hydrophobic 
clusters were concluded to be localized in a-helical 
regions of both the inhibitor and 9 kDa protein 
[7]. Clusters of basic, acidic and hydrophobic 
residues were also found in the 15 kDa protein, 
e.g., residues 62-66, 46-50 and 57-61, respective- 
ly, and these may be involved in complex 
formation. 
The stabilizing factor, 15 kDa protein, which 
has no inhibitory action on ATPase by itself, acts 
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Fig. 1. Summary of sequence studies on the 15 kDa protein. V-, Th-, ST-, and K- refer to the staphylococcal V8 protease 
peptides, thermolysin peptides derived from a V-peptide, tryptic peptides after succinylation, and lysyl endopeptidase 
peptides, respectively. ( d) Solid-phase sequencing by Edman degradation of the protein and peptides, (----_) below 
the sequence indicate manual Edman degradation on peptides. Dotted arrows indicate ambiguous assignments. 
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in concert with the other factor, 9 kDa protein, in 
the stabilization of the complex of FrFa-ATPase 
inactivated by the inhibitor, but not in the 
stabilization of the complex with soluble ATPase. 
The above results and considerations uggest hat 
both stabilizing factors are involved in the binding 
of the Fr-ATPase-inhibitor complex to the 
mitochondrial membrane, as in the case of 
bacterial and chloroplast 6- and &subunits which 
mediate binding of the Fr-portion to the Fa-moiety 
[3]. The apparent A4, of the 15 kDa protein is very 
similar to that of the S-subunit of yeast Fr-ATPase 
[3]. However, the amino acid composition of the 
factor is quite different from that of the d-subunit 
of yeast Fr-ATPase [14], as shown in table 1, and 
the two are immunologically distinguishable [3]. 
The factor resembles the bacterial c-subunit in 
both function and size, and the E. coli e-subunit 
has been reported to have homologous sequences 
with the bovine S-subunit [6]. Therefore, the struc- 
ture of the factor was compared with those of 
other subunits of the Fr-ATPase complex in- 
cluding the inhibitor and the 9 kDa protein. The 
structure of the factor had no distinct homologous 
sequence with that of the E. coli 6- or e-subunit 
[16], or a fragment of the bovine b-subunit [6]. As 
shown in fig.2, however, it showed significant 
homology with the sequences of yeast ATPase 
inhibitor and 9 kDa protein, especially in the 
AI 
9K 
15 K 
AI 
9K 
15 K 
Al 
9K 
15 K E 
Fig.2. Comparison of the amino acid sequences of yeast 
ATPase inhibitor, 9 kDa and 15 kDa proteins. Identical 
and similar amino acid residues in the 15 kDa protein 
and ATPase inhibitor or 9 kDa protein are enclosed in 
solid and dotted boxes, respectively. - indicates a gap 
making alignments highly homologous. The sequence of
ATPase inhibitor is from [13] and that of the 9 kDa 
protein from [7]. AI, 15K and 9K indicate the ATPase 
inhibitor, and the 15 kDa and 9 kDa proteins, 
respectively. 
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carboxyl terminal region. In a previous report, the 
inhibitor and 9 kDa protein were shown to be 
highly homologous with each other and also with 
the E. coli e and bovine S-subunits, and it was sug- 
gested that these proteins were derived from a 
common ancestral gene and then diverged with dif- 
ferent functions [7]. It seems likely that the 15 kDa 
protein was also derived from the common gene of 
these proteins and then evolved further. 
The sequence homology between the 15 kDa 
protein and the yeast J-subunit is unknown 
because the sequence of the b-subunit is not yet 
established. We are now determining the sequences 
of the S- and e-subunits purified from yeast- 
Fr-ATPase. 
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